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SUMMARY
The co-existence of stroke and HIV has increased in recent years, but the impact of HIV on post-
stroke outcomes is poorly understood. We examined the impact of HIV on inpatient mortality,
length of acute hospital stay and complications (pneumonia, respiratory failure, sepsis and
convulsions), in hospitalized strokes in Thailand. All hospitalized strokes between 1 October 2004
and 31 January 2013 were included. Data were obtained from a National Insurance Database.
Characteristics and outcomes for non-HIV and HIV patients were compared and multivariate
logistic and linear regression models were constructed to assess the above outcomes. Of 610 688
patients (mean age 63·4 years, 45·4% female), 0·14% (866) had HIV infection. HIV patients were
younger, a higher proportion were male and had higher prevalence of anaemia (P< 0·001)
compared to non-HIV patients. Traditional cardiovascular risk factors, hypertension and
diabetes, were more common in the non-HIV group (P< 0·001). After adjusting for age, sex,
stroke type and co-morbidities, HIV infection was signiﬁcantly associated with higher odds of
sepsis [odds ratio (OR) 1·75, 95% conﬁdence interval (CI) 1·29–2·4], and inpatient mortality (OR
2·15, 95% CI 1·8–2·56) compared to patients without HIV infection. The latter did not attenuate
after controlling for complications (OR 2·20, 95% CI 1·83–2·64). HIV infection is associated with
increased odds of sepsis and inpatient mortality after acute stroke.
Key words: Complications, HIV, mortality, outcomes, stroke.
INTRODUCTION
The incidence of stroke in low- to middle-income
countries where HIV is prevalent has increased by
over 100% during the past four decades [1].
Co-existence of HIV and stroke has increased and
associations between HIV and stroke have been
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increasingly recognized [2, 3]. Indeed, both these con-
ditions are leading causes of death and disability glo-
bally, and thus their increasing co-existence is of
signiﬁcant public health relevance [4]. An independent
association between HIV and ischaemic stroke has
been demonstrated and, in some cases, stroke has
been the presenting manifestation of HIV [5–7].
Despite this, the impact of HIV on stroke outcome
is poorly understood. In particular, the prognostic
implications of HIV on stroke have never been speciﬁ-
cally investigated. With advances in HIV treatment
associated with improved survival rates, the popula-
tion ageing with HIV will continue to grow with a
likely increasing incidence of non-communicable con-
ditions including stroke.
We investigated the characteristics and prognostic
implications of stroke patients with co-existing HIV
infection in Thailand. Serious and common complica-
tions, inpatient mortality and length of acute inpatient
hospital stay (LOS) after stroke were the selected out-
comes of interest.
METHODS
Data were obtained from the Universal Coverage
Health Security Insurance Scheme Database in
Thailand. Brieﬂy, in Thailand, the whole population
is covered by three insurance schemes: the Civil
Servant Beneﬁt System covers government employees
and their dependants (∼7% of the population). The
Social Security scheme covers private sector em-
ployees (∼13% of the population). The Universal
Coverage Health Security Scheme is a basic health in-
surance scheme covering the rest of the population [8].
All acute hospitalized strokes in Thailand between
1 October 2004 and 31 January 2013 were studied.
We selected this time period as stroke management
in Thailand has become more in line with current
international practice since 2004. Diagnosis of stroke
was identiﬁed from ICD coding (ICD-10 codes
I60-I64) on reimbursement forms. In Thailand, diag-
nosis of stroke is made during an individual’s
inpatient hospital stay by the attending clinical
teams based on clinical features and investigative
ﬁndings including brain imaging. Demographic and
clinical data were obtained from reimbursement
forms using ICD codes, on an annual basis, from
2004 until 2013. Data included age, sex, HIV status,
co-morbidities, stroke type, complications of stroke
occurring during hospital admission (pneumonia, sep-
sis, respiratory failure and convulsions; using ICD
codes), admission and discharge date and inpatient
mortality. Stroke types were categorized as haemor-
rhagic (I61, I62), ischaemic (I63) or stroke of undeter-
mined pathology (I64).
Statistical analysis was performed using Stata
v. 11.2/SE (StataCorp., USA). Statistical signiﬁcance
was assumed where P < 0·05. Descriptive statistics
were calculated separately for individuals with and
without HIV infection and compared.
Post-stroke complications for stroke patients with
HIV were assessed using four logistic regression mod-
els using non-HIV patients as the reference category.
Model A presents an unadjusted analysis; model B
adjusted for age and sex; model C adjusted for age,
sex and stroke type; model D was constructed as
model C with additional adjustment for the three
commonest co-morbid conditions (hypertension, his-
tory of previous stroke and anaemia); and model E
(mortality and LOS outcomes only) was constructed
as in model D with additional adjustment for compli-
cations of stroke (pneumonia, sepsis, respiratory
failure and convulsions). Models were repeated strati-
fying by stroke type. For LOS outcome a linear regres-
sion model was used, but in order to allow for the
non-normal distribution of LOS a bootstrap using
1000 replications was used to estimate the P value
and conﬁdence interval for the mean difference in
LOS between HIV and non-HIV stroke patients.
The study was approved by the Ethics Committee
in Human Research, Khon Kaen University, Khon
Kaen, Thailand.
RESULTS
Between 1 October 2004 and 31 January 2013, 610688
hospitalized stroke patients were identiﬁed and
included in this analysis. Sample mean age was 63·4
years (±14·7 years), 45·4% (n = 276 178) were female
and the prevalence of HIV was 0·14% (n = 866).
Characteristics of the study sample, according to
HIV status, are presented in Table 1. On average,
those with HIV were 22·2 years younger and a higher
proportion were male (P< 0·001). Hypertension and
diabetes were almost ﬁve times more prevalent in the
non-HIV group (P< 0·001) but the overall number
of patients with diabetes in the HIV group was very
low (n = 29). The prevalence of anaemia in the HIV
group was more than double than in the non-HIV
group (P < 0·001). The proportion of individuals
with different types of stroke varied between the two
groups (P < 0·001). Haemorrhagic stroke was
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marginally more common in the non-HIV group while
ischaemic stroke was more common in the HIV group.
The prevalence of stroke of undetermined pathology
was almost double in the non-HIV group compared
to that in the HIV group.
The commonest complications of stroke in this
cohort were pneumonia, sepsis, respiratory failure
and convulsions, and these were therefore selected as
outcomes of interest (Table 2). Overall, stroke compli-
cations were more prevalent in the HIV group, apart
from pneumonia (P= 0·009) and there was no signiﬁ-
cant difference in rates of respiratory failure (P =
0·48). The remaining complications sepsis, convul-
sions and inpatient death were signiﬁcantly more
prevalent in the HIV group (P = 0·004, P< 0·001,
P < 0·001, respectively). Mean LOS was 20% greater
in the HIV group compared to the non-HIV group
(P = 0·002).
Odds ratios (OR) and corresponding 95% conﬁ-
dence interval (CI) for complications of stroke in
patients with HIV are detailed in Table 3. Similarly,
the analysis stratiﬁed by stroke type is presented in
Table 4. After full adjustment, HIV was associated
with higher odds of sepsis (OR 1·75, 95% CI 1·29–
2·4) and mortality (OR 2·15, 95% CI 1·8–2·56).
Additionally controlling for complications did not
attenuate the poor mortality outcome (OR 2·20,
95% CI 1·83–2·64). HIV was associated with a higher
Table 2. Comparison of outcomes after stroke in 610 688 hospitalized stroke patients with and without HIV infection
in Thailand, 2004–2013
Outcome investigated Non-HIV HIV P value
Number (N) 609 802 866
Complication of stroke, % (n)
Pneumonia 9·6 (58 524) 7·2 (62) 0·015
Sepsis 3·2 (19 654) 5 (43) 0·004
Respiratory failure 7·3 (44 333) 6·7 (57) 0·436
Convulsion 3·4 (20 475) 6·4 (55) <0·001
Inpatient death 13·3 (80 977) 20·2 (175) <0·001
Length of inpatient stay (days)
Mean (±S.D.) 7·5 (11·5) 9 (10·6) 0·2909
Table 1. Sample characteristics of 610 688 hospitalized stroke patients with and without HIV infection in Thailand,
2004–2013
Characteristic Non-HIV HIV P value
Number (N) 609 802 866
Age (years)
Mean (±S.D.) 63·5 (14·7) 41·3 (11·3) <0·001
Female sex, % (n) 45·2 (275 911) 30· 8 (267) <0·001
Co-morbidities, % (n)
Hypertension 44·2 (269 562) 9 (78) <0·001
Diabetes 16·5 (100 319) 3·3 (29) <0·001
Previous stroke 7·8 (47 467) 7·4 (64) 0·666
Anaemia 5·4 (32 652) 12·9 (112) <0·001
Rheumatic heart disease 0·9 (5488) 0·3 (3) 0·085
Chronic obstructive pulmonary disease 1·9 (11 591) 0·3 (3) 0·001
Chronic ischaemic heart disease 2·7 (16 344) 0 (0) <0·001
Chronic kidney disease 3·1 (19 188) 0·7 (6) <0·001
Atrial ﬁbrillation 6·1 (37 177) 0·7 (6) <0·001
Heart failure 1·5 (8994) 0·7 (6) 0·056
Stroke type, % (n) <0·001
Haemorrhagic 34·6 (211 117) 30·1 (261)
Ischaemic 50·1 (305 621) 61·3 (531)
Stroke of undetermined pathology 15·3 (93 061) 8·5 (74)
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risk of convulsions in earlier models, in haemorrhagic
and ischaemic stroke, but the associations observed
did not reach statistical signiﬁcance after adjustments.
Overall, HIV was associated with longer LOS but only
model C reached statistical signiﬁcance. However, in
the stratiﬁed analysis, HIV had a higher odds of
longer inpatient stay in ischaemic stroke (OR 2·74,
95% CI 1·8–3·68).
DISCUSSION
Our study is the largest analysis to date of the clinical
characteristics and outcomes of hospitalized strokes in
patients with HIV. In line with previous reports,
stroke patients with HIV were younger and a higher
proportion were male, compared to those without
HIV infection [2, 6, 9, 10]. Traditional stroke risk fac-
tors were more prevalent in the non-HIV group, while
anaemia was more prevalent in the HIV group [11].
We demonstrate a higher rate of post-stroke complica-
tions in patients with HIV and, to the best of our
knowledge, are the ﬁrst group to speciﬁcally report
this. HIV infection had an impact on the likelihood
of developing sepsis during acute hospital stay after
stroke and was associated with increased inpatient
mortality.
The lower prevalence of traditional stroke risk fac-
tors in our HIV cohort supports literature suggesting
that the mechanisms and risks of stroke in HIV are
different from the general population. These include
combination antiretroviral therapies (cARTs), chronic
systemic and opportunistic infections, vasculopathies,
coagulopathies and metabolic and immune dysregula-
tion [12, 13]. As previously reported, ischaemic stroke
was the commonest type of stroke in patients with
HIV [2, 5, 10]. It is perhaps surprising that the preva-
lence of stroke of undetermined pathology was higher
in the non-HIV group. In HIV, neurological compli-
cations, e.g. cerebral toxoplasmosis, are common
and may mimic stroke. These alternative diagnoses,
with different treatment requirements, should always
be considered in HIV patients with suspected stroke.
Our HIV cohort had a higher incidence, and in
some cases risk, of convulsions, sepsis, inpatient mor-
tality and longer LOS than those patients without
HIV. Convulsions were almost twice more frequent
in the HIV group although the fully adjusted ORs
were not statistically signiﬁcant. In a much smaller
sample Hoffman et al. observed a higher prevalence
of seizures on admission in stroke in HIV, but this
was not statistically signiﬁcant [14]. Our ﬁndings
related to increased likelihood of sepsis in HIV- com-
pared to non-HIV-infected stroke patients (fully
adjusted OR 1·75) are not surprising. This is import-
ant because acute inﬂammatory response and sepsis,
in the acute stroke setting, are associated with poorer
outcomes [15, 16]. Our ﬁnding is also in keeping with
reports of co-existent and causative infection in
ischaemic stroke in HIV [10, 14, 17]. It is not clear
why those with haemorrhagic stroke were at highest
risk of sepsis (OR 2·16). It may be because haemor-
rhagic strokes present with more severe neurological
Table 3. Odds ratios (OR) and corresponding 95% conﬁdence intervals (CI) [mean length of stay (LOS)
differences and 95% CI for LOS outcome] for complications of hospitalized stroke in 866 patients with HIV using
609 802 non-HIV patients as the reference category in Thailand, 2004–2013
OR (95% CI)
Complication Model A Model B Model C Model D Model E
Pneumonia 0·73 (0·56–0·94) 1·14 (0·88–1·48) 1·21 (0·93–1·57) 1·01 (0·78–1·32)
Sepsis 1·57 (1·15–2·13) 2·16 (1·59–2·95) 2·17 (1·6–2·96) 1·75 (1·29–2·4)
Respiratory failure 0·9 (0·69–1·18) 1 (0·76–1·31) 1·16 (0·88–1·52) 1·02 (0·78–1·35)
Convulsion 1·95 (1·48–2·57) 1·29 (0·98–1·7) 1·23 (0·94–1·62) 1·05 (0·8–1·38)
Death 1·65 (1·4–1·95) 1·65 (1·4–1·95) 2·29 (1·92–2·73) 2·15 (1·8–2·56) 2·2 (1·83–2·64)
Mean difference in LOS (days) 1·54 (0·84–2·24) 1·55 (0·85–2·25) 2·05 (1·30–2·79) 1·64 (0·89–2·39) 1·11 (0·41–1·82)
Model A: unadjusted analysis.
Model B: analysis adjusted for age and sex.
Model C: analysis adjusted for age, sex and stroke type.
Model D: analysis adjusted for age, sex, stroke type and co-morbidities.
Model E: analysis adjusted for age, sex, stroke type, co-morbidities and complications (pneumonia, sepsis, respiratory failure
or convulsion).
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Table 4. Odds ratios and corresponding 95% conﬁdence intervals (CI) [mean length of stay (LOS) differences and 95% CI for LOS outcome] for complications
of hospitalized stroke in 866 patients with HIV stratiﬁed by stroke type using 609 802 non-HIV patients as the reference category in Thailand, 2004–2013
Stroke type Pneumonia Sepsis Respiratory failure Convulsion Death LOS
Haemorrhagic
Model A 0·6 (0·38–0·95) 1·86 (1·14–3·05) 1·06 (0·74–1·53) 1·88 (1·13–3·12) 1·6 (1·24–2·06) −1·03 (-2·33 to 0·27)
Model B 0·8 (0·51–1·26) 2·23 (1·36–3·65) 1·21 (0·84–1·74) 1·23 (0·74–2·04) 1·82 (1·41–2·34) −0·81 (-2·07 to 0·46)
Model C 0·71 (0·44–1·12) 1·9 (1·15–3·14) 1·14 (0·79–1·65) 1·06 (0·64–1·77) 1·76 (1·37–2·27) −1·28 (−2·53 to −0·03)
Model D — — — — 1·71 (1·32–2·23) −0·88 (-2·19 to 0·43)
Ischaemic
Model A 0·77 (0·56–1·07) 1·34 (0·89–2·01) 0·77 (0·5–1·16) 2·03 (1·45–2·84) 1·98 (1·55–2·54) 2·84 (1·90 to 3·78)
Model B 1·66 (1·19–2·31) 2·25 (1·49–3·4) 1·23 (0·81–1·88) 1·42 (1·01–1·98) 3·16 (2·46–4·05) 3·50 (2·56 to 4·44)
Model Cc 1·3 (0·93–1·82) 1·72 (1·14–2·61) 0·98 (0·65–1·5) 1·19 (0·85–1·66) 2·72 (2·12–3·5) 2·99 (2·05 to 3·93)
Model D — — — — 2·97 (2·27–3·89) 2·74 (1·80 to 3·68)
Undetermined stoke type
Model A 0·98 (0·36–2·67) 1·61 (0·39–6·56) 0·65 (0·09–4·66) 1 (0·24–4·06) 3·09 (1·54–6·22) 1·61 (0·09 to 3·14)
Model B 2·49 (0·9–6·87) 2·89 (0·71–11·86) 1·07 (0·15–7·75) 0·66 (0·16–2·69) 4·71 (2·34–9·51) 2·37 (0·87 to 3·86)
Model C 2·18 (0·79–6·02) 2·54 (0·62–10·44) 1·01 (0·14–7·28) 0·62 (0·15–2·53) 4·36 (2·15–8·8) 2·30 (0·83 to 3·77)
Model D — — — — 4·12 (1·96–8·66) 1·92 (0·46 to 3·38)
Model A: unadjusted analysis.
Model B: analysis adjusted for age and sex.
Model C: analysis adjusted for age, sex and co-morbidities.
Model D: analysis adjusted for age, sex, stroke type, co-morbidities and complications (pneumonia, sepsis, respiratory failure, convulsions.
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deﬁcits, requiring invasive treatment entailing a higher
infection risk.
The higher risk of mortality in stroke in HIV (fully
adjusted OR 2·20) has previously been found, but is
not consistent with all literature [10, 11, 18]. These
smaller single-centre studies may have lacked power
to detect statistically signiﬁcant ﬁndings. Differences
in results may also reﬂect the increasing availability
of cARTs over time, or changes in acute stroke treat-
ment [10]. Our ﬁnding is important because since the
genesis of cART, non-HIV-related conditions, includ-
ing cardiovascular and cerebrovascular disease, have
become the leading causes of death in people with
HIV infection [19]. It is interesting that ischaemic
stroke of undetermined pathology in HIV carried
the highest risk of death (OR 4·12), raising the possi-
bility of serious life-threatening causes of stroke in
these cases. Unfortunately, data on the precise cause
of death were not available from our dataset and so
this was not accounted for in our analysis. In keeping
with the higher prevalence of complications found
here, and with previous literature, mean LOS was
longer in HIV patients, particularly those with ischae-
mic stroke [11].
Overall this study shows that HIV in stroke has
poorer clinical outcomes. We found that, compared
to non-HIV stroke patients, HIV patients with stroke
are younger and have different co-morbid conditions
which may contribute to risk of stroke in HIV and
subsequent clinical sequelae. Alternatively, there
may be a broader spectrum of stroke severity in
older non-HIV stroke patients and that HIV patients
suffer more severe stroke at a younger age, with higher
complication rates. Our dataset did not allow us to
investigate this, but another group have reported
greater stroke severity in HIV while others have
found no differences [9, 10, 18]. Another explanation
for our ﬁndings may be the aetiology of stroke in
HIV. Reported aetiologies of stroke in HIV, e.g. vas-
culopathies may incur more widespread arterial
involvement and hence worsen outcomes [10, 20]. To
this end, our ﬁndings and those in reported literature
reiterate that stroke in HIV is a complex issue.
Our study has some limitations that should be
acknowledged. First, we relied on ICD coding to iden-
tify diagnosis of stroke and co-morbidity data, includ-
ing HIV. Second, our data source meant that detailed
clinical information, e.g. stroke severity and pre-stroke
disability, which are important determinants of out-
come were not available [21]. Third, we did not have
data on cARTs, which may impact stroke outcome.
However, cARTs have been widely available free of
charge throughout Thailand since 2002 [22]. Fourth,
we were not able to study mild strokes not admitted
to hospital and very severe strokes resulting in death
prior to admission. However, the truncation of distri-
bution is only likely to attenuate the results.
Notwithstanding these limitations this work makes
an important contribution to understanding of out-
comes of stroke in HIV. The use of reimbursement
forms as a dataset allowed us to capture an almost
actual population service use for stroke in Thailand
and to study a large nationwide, unselected popula-
tion and availability of outcome data was complete.
CONCLUSIONS
In conclusion, the ﬁndings conﬁrm that the character-
istics of stroke in patients with HIV are different from
those in the general population and show that the
prevalence, and in some instances risk, of sepsis, con-
vulsions, inpatient mortality, and longer LOS stroke
are higher in patients with HIV. Foresight and prompt
treatment of these complications, and any co-existing
illnesses, could potentially help improve outcomes of
stroke in people with co-existing HIV infection.
Future studies should focus on fully establishing risk
factors and mechanisms of stroke in HIV, and devel-
oping optimal treatment strategies for stroke in HIV.
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